bims-axbals Biomed News
on Axonal biology and ALS
Issue of 2026–11–08
nineteen papers selected by
TJ Krzystek



  1. bioRxiv. 2026 Oct 30. pii: 2026.10.29.762862. [Epub ahead of print]
      Neuronal function requires precise transport of lysosomal vesicles along highly polarized processes, yet how this trafficking is spatially and developmentally regulated remains poorly understood. Here, we show that the neuronally enriched kinesin-3 motor KIF1A is required for dendritic and axonal localization of lysosomal vesicles in both immature and mature rat hippocampal neurons. Remarkably, the specialized microtubule environment of the axon initial segment (AIS) restricts KIF1A-driven transport of degradative, cathepsin D-positive lysosomal vesicles while permitting less degradative lysosomal vesicles to enter axons in mature neurons. Disrupting the AIS microtubule environment or expressing a hereditary spastic paraplegia type 30-associated KIF1A variant with increased affinity for GTP-tubulin bypasses this restriction, enabling degradative lysosomal vesicles to enter mature axons. In human iPSC-derived neurons, KIF1A depletion similarly disrupts axonal lysosomal vesicle transport, causes autophagic vesicle accumulation, and triggers axonal degeneration. Together, our findings reveal a developmentally regulated AIS gate that selectively controls KIF1A-driven lysosomal vesicle transport into axons and link its subversion to KIF1A-associated neurological disease.
    DOI:  https://doi.org/10.64898/2026.10.29.762862
  2. Curr Biol. 2026 Nov 03. pii: S0960-9822(26)01362-X. [Epub ahead of print]
      Microtubule dynamics are essential for neuronal development, yet how neurons regulate tubulin levels remains poorly understood. Tetratricopeptide repeat domain 5 (TTC5) mediates tubulin autoregulation, the co-translational degradation of tubulin transcripts in response to excess soluble tubulin, and TTC5 mutations cause cerebral atrophy with speech and motor impairment. Here, we show that tubulin autoregulation is active in induced pluripotent stem cell (iPSC)-derived cortical neurons and depends on TTC5. TTC5 loss, or structure-guided mutations that disable autoregulation suppress microtubule polymerization, axonal outgrowth, and arborization, while enhancing cellular motility. Motility changes extend to non-neuronal cells, where they alter focal adhesion dynamics and can be rescued by manipulating soluble tubulin levels. Furthermore, downregulation of TTC5 interactor and autoregulation mediator S-phase cyclin A-associated protein in the endoplasmic reticulum (SCAPER) also suppresses neurite outgrowth and enhances motility. In vivo, TTC5 loss in mouse cortical projection neurons disrupts axon and dendrite arborization and causes hypermigration, recapitulating the cellular phenotypes observed in vitro. Patient-derived TTC5 disease mutants phenocopy this motility dysregulation, directly linking loss of TTC5 function to neurological deficits seen in patients. Together, these findings establish TTC5 as an essential regulator of neuronal morphogenesis and connectivity, with direct implications for TTC5-associated neurodevelopmental disease.
    Keywords:  SCAPER; TTC5; iPSC-derived neuron; intellectual disability; microtubules; motility; neurological disease; neuronal differentiation; neuronal migration; tubulin autoregulation
    DOI:  https://doi.org/10.1016/j.cub.2026.10.028
  3. Acta Neuropathol Commun. 2026 Aug 08. pii: 229. [Epub ahead of print]14(1):
      Amyotrophic lateral sclerosis (ALS) involves TAR DNA-binding protein 43 (TDP-43) dysfunction, leading to cryptic splicing, including UNC13A cryptic exon inclusion and truncated STMN2 production. Pathologically, ALS is classified into three phosphorylated TDP-43 subtypes (Types 1, 2a, and 2b) based on the distribution of neuronal and glial cytoplasmic inclusions and the density of dystrophic neurites. However, the relationship between these pathological subtypes and TDP-43-associated cryptic splicing remains unclear. This retrospective postmortem study aimed to analyze motor cortex tissue from sporadic ALS cases (Type 1, n = 12; Type 2a, n = 12; Type 2b, n = 11) with previously described subtype-specific morphological features. UNC13A cryptic RNA and truncated STMN2 RNA levels were quantified using quantitative real-time PCR (qRT-PCR). Compared with Types 1 and 2a, Type 2b, characterized by abundant thread-, dot-, and grain-like dystrophic neurites, exhibited significantly higher levels of UNC13A cryptic RNA and truncated STMN2 RNA. Droplet digital PCR revealed a similar subtype-dependent trend and showed strong correlations with qRT-PCR measurements, providing partial support for the primary findings. UNC13A cryptic RNA and truncated STMN2 RNA levels were positively correlated (Spearman's ρ = 0.58), indicating coordinated dysregulation of multiple TDP-43-dependent splicing targets. Our results demonstrate that the burden of TDP-43-associated cryptic splicing differs across ALS pathological subtypes. Additional analyses indicated that these subtype-dependent differences were not readily accounted for by disease duration, RNA quality, normalization strategy, or semiquantitative neuronal loss scores. These findings suggest that molecular heterogeneity parallels pathological heterogeneity in ALS and provide additional insight into the biological diversity of TDP-43 proteinopathy.
    Keywords:   STMN2 ; UNC13A ; Amyotrophic lateral sclerosis; Cryptic splicing; TDP-43
    DOI:  https://doi.org/10.1186/s40478-026-02400-0
  4. J Integr Neurosci. 2026 Oct 26. 25(10): 53852
      Huntington's disease (HD) is an inherited neurodegenerative disorder caused by cytosine-adenine-guanine (CAG) repeat expansion in the huntingtin (HTT) gene, resulting in progressive motor, cognitive, and psychiatric impairment. Despite the widespread expression of mutant huntingtin (mHTT), disease progression is characterized by the selective degeneration of striatal neurons. Mitochondrial dysfunction and impaired mitophagy have emerged as important contributors to HD pathogenesis; however, the mechanisms underlying defective mitochondrial quality control remain incompletely understood. Ras homolog enriched in the striatum (Rhes), a small striatal-enriched guanosine triphosphatase (GTPase), has been implicated in mitophagy-related signalling. In this study, we examined the potential relationship between Rhes and PTEN-induced kinase 1 (PINK1)/Parkin-mediated mitophagy in HD. We propose that Rhes contributes to selective striatal vulnerability by promoting mitochondrial depolarization through BCL2 interacting protein 3-like (NIX/BNIP3L), facilitating activation of the PINK1/Parkin mitophagy pathway, while enhancing autophagosome biogenesis through Beclin-1 signalling. If validated, our proposed pathway would open new avenues for therapeutic development in HD.
    Keywords:  Huntington disease; autophagy; huntingtin protein; mitochondria; mitochondrial diseases; mitophagy; neurodegenerative diseases; neurons; proteins; ubiquitination
    DOI:  https://doi.org/10.31083/JIN53852
  5. Cell Commun Signal. 2026 Aug 08. pii: 596. [Epub ahead of print]24(1):
      Lysosomes are important cellular organelles involved in the recycling of biomolecules in the cell. The acidic intraluminal pH of the lysosome is necessary for the functioning of various hydrolytic enzymes involved in the recycling of biomolecules. Elevated lysosomal pH has been consistently documented in pathological conditions associated with progressive neurodegeneration, including several classical neurodegenerative diseases (e.g., Alzheimer's disease, Huntington's disease) and lysosomal storage disorders or LSDs (e.g., Gaucher disease, CLN3 disease). This review focuses on the molecular mechanisms of lysosomal pH regulation, describing the critical roles of vacuolar ATPases and ion channels in maintaining lysosomal pH homeostasis. Further, we highlight how defective acidification of the lysosome can promote common cellular defects linked with both classical neurodegeneration and LSDs. The review also draws a parallel between the pathological consequences of experimentally-induced lysosomal alkalinization and two complex classes of disorders: classical neurodegeneration and LSDs. This comparison raises the possibility that lysosomal pH is one of the multiple shared contributing mechanisms for both conditions and, therefore, a conceivable therapeutic target of classical neurodegeneration and LSDs.
    Keywords:  Lysosomal acidification; Lysosomal alkalinization; Lysosome; Lysosome Storage Disorder; Neurodegeneration
    DOI:  https://doi.org/10.1186/s12964-026-03118-1
  6. Bioessays. 2026 Nov;pii: e70200. [Epub ahead of print]48(11):
      STMN2, a protein implicated in motor neuron degeneration, is widely viewed as a membrane-associated microtubule inhibitor, but emerging evidence challenges whether this activity defined its cellular function. Three alternative models integrates available evidence to offer perspectives beyond microtubule regulation. The vesicle cargo adaptor model proposes that STMN2 recruits diverse cargos to transport vesicles for axonal delivery. The membrane-bound signaling messenger model links STMN2 turnover to local signaling, effector, degradation, or effector release. The traffic director model proposes that STMN2 regulates cargo routing between delivery and degradative pathways. These models are not mutually exclusive and position tubulin binding as a regulator of STMN2 function rather than its defining activity.
    Keywords:  TDP‐43 proteinopathy; amyotrophic lateral sclerosis; axoplasmic transport; cell biology; cellular regulation; microtubule; neurodegeneration; regenerating axons; stathmin; tubulin
    DOI:  https://doi.org/10.1002/bies.70200
  7. bioRxiv. 2026 Oct 30. pii: 2026.10.27.761477. [Epub ahead of print]
      This study establishes a unified pipeline for generating human induced pluripotent stem cell (iPSC)-derived motor neurons (iMNs) with defined hindbrain, cervical, and lumbar identities to support anatomically resolved studies of motor neuron development and degeneration. Conventional differentiation methods can efficiently produce iMNs but provide limited control over rostrocaudal identity and frequently generate populations with heterogeneous HOX profiles. We addressed this limitation by optimizing developmental morphogen combinations and treatment windows, establishing three complementary protocols that reproducibly generated hindbrain/rhombomere-associated motor neurons (RiMNs), cervical motor neurons (CiMNs), and lumbar motor neurons (LiMNs) across iPSC lines from six non-diseased donors balanced by sex. Transcriptomic and protein analyses demonstrated graded rostrocaudal specification from RiMNs through CiMNs to LiMNs, together with region-appropriate motor neuron subtype features. These identities showed the expected relationships to human week 9 fetal rostrocaudal HOX programs. High-density multielectrode array analysis further revealed synchronized network firing, electrically active neurite networks, and enhanced axonal signal propagation in the regional iMN populations compared with conventionally differentiated iMNs. Spike-sorted recordings additionally revealed protocol-associated differences in single-neuron electrophysiological profiles. Together, this three-protocol pipeline enables the reproducible generation and comparative analysis of anatomically defined human motor neuron populations and provides region-matched cellular models for investigating motor neuron development, selective degeneration, and therapeutic responses.
    DOI:  https://doi.org/10.64898/2026.10.27.761477
  8. BMC Neurosci. 2026 Aug 06. pii: 55. [Epub ahead of print]27(1):
      Current treatments for spinal muscular atrophy have significantly improved patient prognosis, but still fall short of a full cure, particularly when administered after symptom onset. To improve future therapies, it is essential to identify the early pathological events that currently limit treatment efficacy. Here we have investigated the vulnerability and maturation of intramuscular motor axons in the SmnΔ7 mouse model of spinal muscular atrophy using a panel of cranial muscles with differing susceptibility to disease. We demonstrate that although there is intermuscular heterogeneity in neuromuscular junction pathology, they are united by a common loss of motor axons. We show that the timing of motor axon loss differs between muscles, but that motor axon loss precedes structural denervation and can occur by postnatal day 1 in highly vulnerable muscles. Electron microscopy of intramuscular axons revealed that axonal maturation and myelination are grossly normal prior to subsequent postnatal degeneration. We note that axons lack the traditional morphological correlates of axon degeneration but can be visualised using antibodies which detect degenerating neurofilaments. Treatment with SMN-upregulating therapy SMN-C8 at best preserves intramuscular axons when administered before the onset of degeneration but is unable to reverse damage or promote regeneration once axon loss has occurred. Collectively this data demonstrates that SMN-upregulating therapy can prevent motor axon loss, but the capacity is limited by the number of intramuscular axons which remain at the time of treatment onset. This work highlights the importance of developing complementary therapies which can promote motor axon regeneration to act in synergy with SMN-upregulating compounds.
    Keywords:  Axon; Motor neurons; Mouse models, SMN-upregulating therapy; Spinal muscular atrophy
    DOI:  https://doi.org/10.1186/s12868-026-01034-1
  9. Redox Biol. 2026 Nov 04. pii: S2213-2317(26)00468-4. [Epub ahead of print]98 104469
      Transactive response (TAR) DNA-binding protein 43 (TDP-43) is a multifunctional DNA/RNA binding protein. Cytoplasmic TDP-43 aggregation is a pathological hallmark of diverse neurodegenerative diseases collectively termed TDP-43 proteinopathy. Oxidative stress is closely associated with TDP-43 aggregation and neurotoxicity in TDP-43 proteinopathy, yet the underlying molecular mechanisms remain elusive. To delineate molecular basis of TDP-43 proteinopathy, we conducted deep quantitative proteomic profiling using a Neuro-2a (N2a) neuronal cell model of human wild-type TDP-43 overexpression (N2a-hTDP-43). We identified thioredoxin-1 (Trx1) as a central node linking mitochondrial dysfunction and redox dysregulation to TDP-43 pathology. Consistent with this, TDP-43 overexpression markedly reduced Trx1 protein levels. Moreover, inhibiting Trx1 exacerbates, whereas overexpressing Trx1 alleviates, cytoplasmic TDP-43 aggregation and neurotoxicity in N2a-hTDP-43 cells. Furthermore, overexpressing Trx1 alleviates TDP-43-associated pathologies in mouse primary neurons. Notably, we identified that cytoplasmic TDP-43 protein sequesters Trx1 mRNAs into insoluble TDP-43 inclusions, leading to its translational suppression. We also demonstrated that suppression of Trx1 is a core mechanism eliciting oxidative stress and mitochondrial dysfunction in TDP-43 overexpression model. Importantly, in human induced pluripotent stem cell (iPSC)-derived motor neurons (MN) harboring the pathogenic TDP-43 M337V mutation (TDP-43M337V iPSC-MNs), Trx1 expression is downregulated, concomitant with increased oxidative stress, compared to the isogenic TDP-43WT iPSC-MN control. Furthermore, inducing Trx1 expression markedly reduces oxidative stress and cytoplasmic TDP-43 aggregation in TDP-43M337V iPSC-MNs, suggesting conserved neuroprotective role of Trx1 in TDP-43 proteinopathy in human. Collectively, we identified Trx1 as a pivotal regulator of TDP-43 proteinopathy, highlighting therapeutic potential of Trx1 for TDP-43 proteinopathies.
    Keywords:  Cytoplasmic aggregation; Mitochondrial dysfunction; Oxidative stress; TDP-43 proteinopathy; Thioredoxin 1
    DOI:  https://doi.org/10.1016/j.redox.2026.104469
  10. bioRxiv. 2026 Oct 28. pii: 2026.10.25.761709. [Epub ahead of print]
      A GGGGCC (G 4 C 2 ) hexanucleotide repeat expansion in the first intron of C9orf72 is the most common monogenic cause of Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). This element serves as a template for repeat-associated non-AUG (RAN) translation, which generates neurotoxic dipeptide repeat (DPR) proteins that aggregate in patient brains and contribute to neurodegeneration in model systems. To understand the mechanisms underlying RAN translation initiation, we used cryo-electron microscopy to determine the structure of an in vitro assembled human late-stage C9orf72 translation initiation complex at 3.2 Å resolution and a near-native complex purified from human cell lysate at 3.5 Å resolution. RAN translation on C9orf72 mRNA initiates predominantly at a near-cognate CUG codon that is located 24 nucleotides upstream of the G 4 C 2 repeat and is flanked by a strong endogenous Kozak sequence. The structures further reveal a direct interaction between the G 4 C 2 repeat and 18S ribosomal RNA expansion segment 9 (ES9S) on the 40S small ribosomal subunit through a kissing-loop interaction. Preventing this RNA-RNA interaction using complementary antisense oligonucleotides significantly reduces RAN translation in vitro and in patient-derived iNeurons, indicating that this structural interaction is functionally important. These findings provide mechanistic insights into RAN translation initiation and highlight a novel potential therapeutic approach to mitigate toxic DPR production in C9orf72-associated neurodegenerative disease.
    DOI:  https://doi.org/10.64898/2026.10.25.761709
  11. J Biomed Sci. 2026 Nov 04. pii: 94. [Epub ahead of print]33(1):
       BACKGROUND: Pathological aggregation of Tar DNA-binding protein 43 (TDP-43) and disruption of neuronal protein homeostasis are defining features of amyotrophic lateral sclerosis (ALS), frontotemporal lobar degeneration (FTLD), and related TDP-43 proteinopathies. Efficient axonal transport of proteasomes is essential for maintaining local protein quality control in neurons. Proteasome inhibitor 31 (PI31) regulates both 26S proteasome assembly and dynein-mediated transport of 20S proteasomes. Although Tankyrase 1/2 (TNKS)-mediated ADP-ribosylation of PI31 promotes 26S proteasome assembly, its role in proteasome transport and its contribution to TDP-43 pathology remain unclear.
    METHODS: Live-cell imaging was performed to examine 20S proteasome transport in primary cortical and motor neurons from wild-type and Prp-TDP-43A315T transgenic mice. Protein interactions among TDP-43, TNKS, and PI31 were analyzed by immunoprecipitation and Förster resonance energy transfer (FRET). Insoluble protein accumulation and colocalization were assessed by RIPA/urea fractionation, Western blotting, and immunofluorescence. Proteasome assembly and activity were evaluated using native gel electrophoresis and a 20S proteasome-specific fluorogenic substrate. TDP-43 aggregation was examined by semi-denaturing detergent agarose gel electrophoresis (SDD-AGE).
    RESULTS: In cell models expressing TDP-43-FL, TDP-43-A315T, or TDP-25 and in Prp-TDP-43A315T transgenic mice, pathological TDP-43 species formed distinct aggregates, ranging from oligomers to prominent cytoplasmic aggregates, yet all reduced proteasome activity, impaired axonal proteasome transport, and caused the accumulation of polyubiquitinated proteins, PI31, 20S proteasomes, and TDP-43 in the proximal axon and cell body. Pathological TDP-43 sequestered TNKS and proteasome components into insoluble fractions, thereby limiting the availability of free and soluble TNKS for interaction with PI31 and subsequent PI31 ADP-ribosylation, ultimately impairing 19S/20S proteasome assembly. Notably, disruption of the TNKS-PI31 interaction or inhibition of TNKS activity recapitulated the proteasome dysfunction induced by pathological TDP-43, supporting a role for the aberrant TNKS-TDP-43 interaction and consequent impairment of TNKS-mediated PI31 ADP-ribosylation in TNKS/PI31/proteasome axis dysfunction.
    CONCLUSIONS: Pathological TDP-43 disrupts proteasome function by impairing the TNKS/PI31/proteasome axis, suggesting that this axis may represent a potential therapeutic target for TDP-43 proteinopathies. Selectively restoring this pathway may enhance pathological TDP-43 clearance while minimizing nonspecific proteasome activation, thereby providing a more precise and safer therapeutic strategy for ALS and FTLD.
    Keywords:  ADP-ribosylation; ALS; Axon transport; Live cell imaging; PI31; Proteasome activity; Protein homeostasis; TDP-43; TNKS
    DOI:  https://doi.org/10.1186/s12929-026-01296-1
  12. Elife. 2026 Nov 03. pii: RP111349. [Epub ahead of print]15
      A substantial fraction of amyotrophic lateral sclerosis (ALS)-associated proteins remains poorly characterized, in part because of the limited availability of validated research antibodies. We established knockout (KO)-based antibody characterization workflows and demonstrated that widely used antibodies against the major ALS-associated protein C9orf72 lacked specificity (Laflamme et al., 2019). We subsequently scaled this framework to systematically benchmark research antibodies, revealing that up to 61% fail to perform as recommended by manufacturers (Ayoubi et al., 2023b). Here, we extend this approach by establishing the ALS-Reproducible Antibody Platform (ALS-RAP), a comprehensive effort to generate a publicly available dataset of KO-validated antibodies targeting proteins encoded by ALS risk genes. In total, we characterized 303 antibodies against 33 ALS-associated proteins to identify high-quality reagents for use in western blot, immunoprecipitation, and immunofluorescence. Using these antibodies, we profiled protein levels across human induced pluripotent stem cell-derived and primary neurological cell types. These analyses revealed diverse cellular distributions and higher levels of several ALS-associated proteins in glial populations, consistent with emerging evidence for immune contributions to ALS. Together, ALS-RAP provides a validated antibody toolbox and protein expression resource to support the study of ALS-associated proteins.
    Keywords:  ALS; amyotrophic lateral sclerosis; antibody characterization; cell biology; human; neuroscience; open science; protein expression profiling
    DOI:  https://doi.org/10.7554/eLife.111349
  13. Cell Death Dis. 2026 Aug 11. pii: 944. [Epub ahead of print]17(1):
      While predominantly nuclear localized in healthy cells, TDP-43 can transit between the nucleus and cytoplasm. In frontotemporal lobar degeneration (FTLD-TDP) and amyotrophic lateral sclerosis (ALS), TDP-43 accumulates in hyperphosphorylated cytoplasmic aggregates. However, a subset of patients develops nuclear aggregates. Expression of wild-type TDP-43 in C. elegans neurons results in nuclear protein accumulation and toxic gain of function. To enable comparative study of nuclear and cytoplasmic TDP-43 phenotypes, we generated new models with inactivating mutations in the nuclear localization sequence (NLS) of TDP-43. When compared to nuclear TDP-43 strains, similar protein levels of cytoplasmic TDP-43 cause less neuronal dysfunction in C. elegans. Using RNA sequencing, we determine that transcriptomes are largely unchanged in these models. However, we identify innate immune pathway increases in response to cytoplasmic but not nuclear TDP-43. We find phosphorylation-mediated neurotoxicity of both cytoplasmic and nuclear localized TDP-43 is controlled by the phosphatase calcineurin. We also find that overexpression of the unfolded protein response (UPR) transcription factor XBP-1s worsens outcomes for wild-type TDP-43 animals but improves TDP-43 ΔNLS, suggesting different pathways controlling toxicity and clearance of nuclear versus cytoplasmic TDP-43. Taken together, these data support shared and distinct cellular responses to nuclear versus cytoplasmic TDP-43 localization in an intact animal nervous system. This comparative approach supports a better understanding of human disease and informs therapeutic development for pathological subtypes of TDP-43 proteinopathies.
    DOI:  https://doi.org/10.1038/s41419-026-09143-9
  14. J Clin Invest. 2026 Nov 02. pii: e206733. [Epub ahead of print]136(21):
      Transmembrane protein 175 (TMEM175), implicated in Parkinson's disease (PD) risk, has been variably proposed to function as a background K+ "leak" channel or a proton-activated proton channel in lysosomes. Here, we identified the rare TMEM175 variant p.L275R in a patient with early onset PD. Electrophysiological analyses revealed that TMEM175-L275R mutant proteins retain normal lysosomal expression and K+ "leak" activity, but specifically lose proton- and agonist-dependent activation gating. In skin fibroblasts isolated from the patient with PD harboring the monoallelic p.L275R mutation (TMEM175+/L275R), and in derived induced pluripotent stem cells and induced dopaminergic neurons, lysosomal H+ flux, acidification, and degradation were impaired. These lysosomal defects were corrected upon genome editing to produce the isogenic WT allele (+/+Cor), but appeared when the mutant allele was introduced onto a WT background (+/L275RMut). Pathological α-synuclein aggregation was facilitated in patient-derived (+/L275R) and mutation-introduced (+/L275RMut) neurons. Consistent with these genetic findings, pharmacological activation of TMEM175 with small-molecule agonists restored lysosomal functions and reduced α-synuclein aggregation in TMEM175+/L275R neurons. In in-vivo studies, equivalent-site-mutation knock-in mice demonstrated synucleinopathy and PD-like motor phenotypes. Collectively, our work provides genetic and pharmacological evidence that severe loss-of-function mutations may contribute causally to the onset age and pathogenesis of PD and identifies lysosomal proton channels and transporters as potential therapeutic targets for PD intervention.
    Keywords:  Aging; Cell biology; Development; Ion channels; Lysosomes; Parkinson disease
    DOI:  https://doi.org/10.1172/JCI206733
  15. J Cell Biol. 2027 Jan 04. pii: e202602115. [Epub ahead of print]226(1):
      Neural circuit maturation requires precise elimination of transient synaptic connections, but how electrical synapses are eliminated remains unknown. Using Caenorhabditis elegans PLM mechanosensory neurons, we found that gap junctions form transiently during early development and are subsequently eliminated as the circuit matures. These transient electrical synapses drive high-frequency calcium oscillations; optogenetic ablation of early gap junctions abolishes calcium dynamics and disrupts chemical synapse formation, while restoring calcium activity independently of gap junction coupling substantially rescues this defect, directly linking electrical synapse-driven calcium dynamics to chemical synapse formation. Through forward genetic screening, we identified the conserved kinase UNC-51/ULK as essential for elimination. UNC-51 phosphorylates the kinesin adaptor UNC-76/FEZ to promote RAB-10-dependent net retrograde removal of innexins, progressively depleting innexin proteins from the synaptic site. Disrupting this pathway prevents elimination, causing persistent electrical synapses and neuronal hyperactivity. These findings establish a conserved framework for developmental elimination of functionally essential transient electrical connectivity.
    DOI:  https://doi.org/10.1083/jcb.202602115
  16. bioRxiv. 2026 Nov 01. pii: 2026.10.01.756094. [Epub ahead of print]
      Postmitotic neurons depend on continuous DNA repair to preserve genome integrity, yet the polymerases supporting repair-associated DNA synthesis remain poorly defined. Here, we identify DNA polymerase kappa (POLK), a Y-family translesion synthesis polymerase studied predominantly in proliferating cells, as a regulator of DNA synthesis and genome maintenance in postmitotic neurons. Using primary mouse cortical neurons and human induced pluripotent stem cell-derived forebrain neurons, we show that POLK localizes near newly synthesized DNA and repair-associated proteins, including ubiquitinated PCNA. POLK depletion reduces DNA synthesis in both mouse and human neurons and promotes nuclear and organelle remodeling, p21-associated senescence-like stress, inflammatory responses, and increased p38 MAPK immunoreactivity. In an Alzheimer's disease-risk genetic background, POLK depletion also increases cytoplasmic double-stranded DNA and tau phosphorylation. Conversely, POLK overexpression enhances neuronal DNA synthesis while reducing DNA damage-associated signals, p38 MAPK immunoreactivity, cytoplasmic DNA, and Alzheimer's disease-relevant phenotypes. These findings uncover a role for POLK in postmitotic neuronal genome maintenance, linking specialized DNA polymerase function to neuronal stress and vulnerability relevant to aging and neurodegeneration.
    DOI:  https://doi.org/10.64898/2026.10.01.756094
  17. Mol Neurobiol. 2026 Oct 31. pii: 1007. [Epub ahead of print]63(1):
      Maintenance of protein homeostasis is essential for neuronal survival, and its disruption is a defining feature of neurodegenerative diseases. Neurons are particularly vulnerable to proteostatic stress due to their post-mitotic nature, long lifespan, and dependence on cytoskeletal integrity for structural stability, intracellular transport, and synaptic function. In tauopathies and related neurodegenerative disorders, misfolded proteins and aggregation-prone proteins burden the cellular quality-control systems, leading to cytoskeletal destabilization, synaptic dysfunction, and progressive neuronal loss. This review is organized around a central question: for a given tau species, defined by its isoform, post-translational modifications, and assembly state, what determines its fate? We examine how molecular chaperone networks, including HSP100, HSP90, HSP70, J-domain proteins (JDPs), small heat shock proteins (sHSPs), and the Prefoldin-CCT pathway, regulate the folding, disaggregation, sequestration, and degradation of pathogenic tau. We highlight how these chaperone networks influence key proteostasis checkpoints, determine whether tau refolds, is degraded, or is redirected toward toxic aggregation, and how these outcomes impact microtubule stability and neuronal function. Drawing on studies in yeast, Drosophila, mammalian models, and human tissues, we develop two key conclusions. First, chaperone activity is not uniformly protective against tauopathies; its effects depend on the tau species, cellular context, and disease stage. Second, because the cytoskeleton is both a chaperone client and an essential component of intracellular clearance pathways, tau pathology and proteostasis failure can reinforce one another. Finally, we discuss emerging therapeutic strategies and challenges in targeting chaperone networks to restore proteostasis while avoiding unintended neurotoxic consequences.
    Keywords:  Cytoskeletal dysfunction; Heat shock proteins; Molecular chaperones; Protein aggregation; Proteostasis; Tauopathy
    DOI:  https://doi.org/10.1007/s12035-026-06310-z
  18. bioRxiv. 2026 Oct 27. pii: 2026.10.26.761970. [Epub ahead of print]
      Alzheimer's disease (AD) is the most common progressive neurodegenerative disease for which there is currently no safe and effective treatment. AD is characterized by the pathological aggregation of amyloid-β (Aβ) in the brain resulting in neuronal dysfunction/death and cognitive decline. Modeling these processes in vitro remains challenging due to the lack of an immune-competent 3D in vitro human model of AD amenable to high-throughput analyses. Conventional cerebral organoids (COs) lack microglia and are optically dense which precludes real-time longitudinal analyses. Here, we employ the fluorescent amyloid probe PyrPeg to selectively monitor Aβ aggregation, and calcein AM and propidium iodide to assess cellular viability within microglia-containing COs (MCOs). We identify age-dependent DS-AD-associated phenotypes within T21 MCOs including Aβ neuropathology, neurodegeneration, and glial cell dysregulation. Our platform supports real-time, multiplexed tracking of disease progression and provides a scalable platform for longitudinal analyses studying disease mechanisms and targeted approaches to treatment.
    Motivation: High-throughput in vitro drug screening using cerebral organoids (COs) has great potential to accelerate drug discovery efforts for treating Alzheimer's disease (AD) and other neurodegenerative diseases. However, live fluorescence imaging of COs has proved challenging due to their dense, optically opaque tissue. Furthermore, conventional COs lack microglia which are key immunomodulators of pathogenesis in the AD brain. To address these limitations, we developed and optimized a live organoid imaging approach employing the fluorescent amyloid-binding probe PyrPeg to label amyloid-β (Aβ) aggregates within human induced pluripotent stem cell (hiPSC)-derived microglia-containing COs (MCOs). We achieved selective labeling and visualization of Aβ neuropathology in intact live MCOs and observed increased age-associated Aβ accumulation in MCOs derived from donors with trisomy 21 (T21) relative to disomy 21 (D21), consistent with the Down syndrome-associated AD (DS-AD) phenotype in the human brain. This method establishes a platform for high-throughput longitudinal drug screening in immunocompetent human COs that will enable the identification of new therapeutic candidates to modulate Aβ aggregation, glial reactivity, and neurodegeneration.
    Highlights: A platform was developed for high-resolution in vitro visualization of insoluble Aβ aggregates in live MCOs. The approach enables deep tissue imaging of Aβ pathology in intact 3D MCOs, allowing spatial mapping of Aβ aggregate distribution over time.Differences in Aβ burden and viability of neurons, neural progenitors, and astrocytes were quantified, distinguishing T21 COs from D21 control MCOs.The platform is positioned to support high-throughput longitudinal drug screening, providing a scalable tool to identify novel therapeutics targeting Aβ-mediated neurodegeneration.
    DOI:  https://doi.org/10.64898/2026.10.26.761970
  19. J Cell Sci. 2026 Nov 01. pii: jcs264858. [Epub ahead of print]139(21):
      Organelles communicate with each other by building membrane contact sites (MCSs) via specialized protein-protein and/or protein-membrane interactions. Conventional light microscopy cannot distinguish organelles connected by MCSs from those merely juxtaposed. In addition, organelle contacts are dynamic, yet only a limited number of tools are available to monitor MCSs in living cells. In this study, we developed a series of reporters based on dimerization-dependent fluorescent proteins (ddFP) to visualize, quantify and follow inter-organelle contacts. We first generated an integrated system specifically designed to study contacts between late endocytic compartments (late endosomes and lysosomes) and the endoplasmic reticulum (ER). This system utilizes a single plasmid coding for the two complementary ddFP components: green A (GA) and green B (GB) targeted to the ER and late endosomes and lysosomes (LE/Lys), respectively. This construct enabled the generation of a stable reporter cell line suitable for semi-quantitative imaging. The ddFP reporter, which we called ddFP LELYS-ER, did not perturb endogenous LE/Lys-ER contacts in stable cells, and detected changes in the number of LE/Lys-ER contacts, for example, upon downregulation of the ER-resident VAP tether protein family, or under conditions of lysosomal damage. Moreover, live-cell imaging revealed that LE/Lys-ER contacts have distinct shapes, mobilities and lifetimes. Finally, using the same vector design, we generated two additional integrated reporter systems adapted to the study of contacts between the ER and the plasma membrane, and between the ER and mitochondria.
    Keywords:  Dimerization-dependent fluorescent protein; Endoplasmic reticulum; Endosomes; Lysosomes; Membrane contact sites; Mitochondria; Organelles; Plasma membrane
    DOI:  https://doi.org/10.1242/jcs.264858